Navigation Links
S. cerevisiae yeast Whole Genome from Agilent Technologies

ProductsS. cerevisiae yeast Whole Genome from Agilent Technologies
Company Agilent Technologies
Item S. cerevisiae yeast Whole Genome
Price 
Description The Yeast Whole Genome ChIP-on-chip Microarray is specifically designed for location analysis of yeast (S. cerevisiae) DNA binding proteins by pairing chromatin immunoprecipitation (ChIP) with Agilent DNA microarrays. This set delivers robust hybridization and reliable binding data with greater true binding events and fewer false positives. In addition, Agilent provides flexibility by offering both a high resolution yeast microarray as well a multi-array slide format.
Info Agilent TechnologiesAgilent Technologies


US and Canada
395 Page Mill Rd.
P.O. Box #10395
Palo Alto, CA 94303
USA

For Agilent contacts in other countries
please click here.

Customer Service: 1-800-227-9770/1-302-993-5304
Web Site: http://www.agilent.com/chem
NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. EBY100 S. cerevisiae Strain from Invitrogen
2. Bakers yeast (S. cerevisiae) Phosphoglucose isomerase from Sigma-Aldrich
3. Bakers yeast (S. cerevisiae) S-Acetyl-coenzyme A synthetase from Sigma-Aldrich
4. Enolase from bakers yeast (S. cerevisiae) from Sigma-Aldrich
5. Bakers yeast (S. cerevisiae) Hexokinase and glucose-6-phosphate dehydrogenase from Sigma-Aldrich
6. S. cerevisiae Direct Transformation Kit from Wako Chemicals USA, Inc.
7. S. cerevisiae Direct Transformation Kit from Wako Chemicals USA, Inc.
8. S. cerevisiae yeast Whole Genome from Agilent Technologies
9. Ribonucleic acid, transfer from bakers yeast (S. cerevisiae) from Sigma-Aldrich
10. Ribonucleic acid, transfer from bakers yeast (S. cerevisiae) from Sigma-Aldrich
11. Ribonucleic acid, transfer from bakers yeast (S. cerevisiae) from Sigma-Aldrich
... Isoaspartate Detection Kit is intended for quantitative ... and peptides, which can result from the ... of aspartic acid residues during storage or ... on the monitoring of charge differences for ...
...
...
Rb anti-Occludin (C-term GST)...
Biology Products:
(Date:6/29/2015)... Research and Markets( http://www.researchandmarkets.com/research/zj7h4f/latin_america ... America Biomedical Sensors Market - Growth, Trends & Forecasts ... Latin America Biomedical Sensors market is estimated at $0.65 ... the period 2014-2020 The near future will ... formulation of each individual. These sensors can be set ...
(Date:6/25/2015)... June 25, 2015 According ... Type (Swipe & Area), Technology, Material (Optical Prism, ... Commercial Security & Others) & Geography - Global ... the said market is expected to reach $14,500.07 ... Browse 76 market Tables and ...
(Date:6/25/2015)... 2015  TAKE Solutions Ltd., a global business technology ... States Patent and Trademark Office (USPTO) for its "Method ... Solutions, Clinical Accelerators to reduce the time taken to ... standardization without the accelerators), thus reducing time to market. ... At the heart of the patented Clinical Data Standardization ...
Breaking Biology News(10 mins):Latin America Biomedical Sensors Market Report 2015-2020 2Fingerprint Sensors Market Worth $14,500.07 Million by 2020 2Fingerprint Sensors Market Worth $14,500.07 Million by 2020 3Fingerprint Sensors Market Worth $14,500.07 Million by 2020 4TAKE Solutions Awarded Patent By USPTO 2
... Levels of heme oxygenase-1 (HO-1), an antioxidant that protects ... direct tissue injury), become elevated in the lungs of ... approach for the disease. , These results appear in ... Journal of Respiratory and Critical Care Medicine, published by ...
... or fighting like a boy is hardwired into fruit fly ... Neuroscience advance online publication by a research team from Harvard ... The results confirm that a gene known as "fruitless" is ... mark a milestone in an unlikely new animal model for ...
... are emerging and action must be taken soon before ... week's BMJ. , The authors say that urgent action ... in countries where tuberculosis control practices have been inadequate. ... of the spread of these highly drug resistant strains ...
Cached Biology News:Antioxidant protects against lung damage in silicosis 2Fighting like a girl or boy determined by gene in fruit flies 2Fighting like a girl or boy determined by gene in fruit flies 3World-wide warning of highly drug-resistant tuberculosis 2
(Date:7/1/2015)... 2015   Neuraltus Pharmaceuticals, Inc. , a privately-held ... drugs to treat neurodegenerative diseases such as amyotrophic ... G. Miller , M.D., Director of the Forbes Norris ... Medical Center in San Francisco, has been awarded a ... to help fund a Phase 2 clinical study ...
(Date:7/1/2015)... ... July 01, 2015 , ... Apex Therapeutics announced today ... Convention in Philadelphia, PA. , The presentation took place on Tuesday, June ... plans for the development of APX3330 for the treatment of pancreatic cancer. A ...
(Date:6/30/2015)... /PRNewswire/ - Resverlogix Corp. ("Resverlogix") (TSX:RVX) announced today ... have approved the resolutions relating to: (i) a ... units at a price of $2.67 per unit ... of one common share and 0.075358 common share ... million; and (ii) the amendment to Resverlogix,s articles ...
(Date:6/30/2015)... San Francisco, CA (PRWEB) , ... June 30, ... ... in FMT Patients , Study will provide new insights on mechanics of fecal ... announced a new partnership to study the microbiome of patients undergoing fecal microbiota ...
Breaking Biology Technology:Investigator to Receive $1.5 Million Grant from the ALS Association to Help Fund Confirmatory Phase 2 Study of Neuraltus Pharmaceuticals' NP001 2Investigator to Receive $1.5 Million Grant from the ALS Association to Help Fund Confirmatory Phase 2 Study of Neuraltus Pharmaceuticals' NP001 3Investigator to Receive $1.5 Million Grant from the ALS Association to Help Fund Confirmatory Phase 2 Study of Neuraltus Pharmaceuticals' NP001 4Apex Therapeutics Presented Company Overview at This Year’s BIO International Convention in Philadelphia, PA 2Resverlogix Corp. Shareholders Approve Matters Relating to Licensing and Equity Arrangement 2Resverlogix Corp. Shareholders Approve Matters Relating to Licensing and Equity Arrangement 3uBiome and OpenBiome Partner for Microbiome Study in FMT Patients 2uBiome and OpenBiome Partner for Microbiome Study in FMT Patients 3